150
Participants
Start Date
October 28, 2025
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2027
Temple University, Philadelphia
Wake Forest University Health Sciences, Winston-Salem
University of Louisville, Louisville
Texas Tech University Health Science Center (TTUHSC), El Paso
Mayo Clinic Arizona, Scottsdale
Massachusetts General, Boston
Collaborators (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Massachusetts General Hospital
OTHER
Temple University
OTHER
University of Louisville
OTHER
Wake Forest University
OTHER
Texas Tech University Health Sciences Center, El Paso
OTHER
Mayo Clinic
OTHER
Johns Hopkins Bloomberg School of Public Health
OTHER